Milacron Holdings Corp. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, the company reported net sales of $314.7 million against $292.7 million a year ago. Operating earnings was $29.6 million against $29.1 million a year ago. Earnings before income taxes was $18.5 million against $13.9 million a year ago. Net earnings was $12.3 million against loss of $6.7 million a year ago. Earnings per basic and diluted share was $0.17 against loss of $0.10 a year ago. Adjusted EBITDA was $57.3 million against $54.3 million a year ago. Adjusted net income totaled $31.0 million, or $0.44 per diluted share compared to adjusted net income of $25.1 million, $0.36 per diluted share in the prior year period. Cash flow from operations was $11.4 million against $4.0 million a year ago. Negative free cash flow was $0.3 million against free cash flow of $1.5 million a year ago.

For the nine months, the company reported net sales of $909.3 million against $877.6 million a year ago. Operating earnings was $77.9 million against $96.8 million a year ago. Earnings before income taxes was $18.8 million against $51.2 million a year ago. Net loss was $2.2 million against earnings of $29.4 million a year ago. Loss per diluted share was $0.03 against earnings per diluted share of $0.42 a year ago. Net cash provided by operating activities was $7.4 million against $60.8 million a year ago. Purchases of property and equipment was $34.3 million against $31.0 million a year ago. Adjusted EBITDA was $166.9 million against $159.2 million a year ago. Adjusted net income totaled $86.2 million, or $1.22 per diluted share compared to adjusted net income of $72.9 million, or $1.04 per diluted share in the prior year period. Negative free cash flow was $12.3 million against free cash flow of $30.6 million a year ago.

The company revised earnings guidance fore the year 2017. The company forecasts 3.0% to 3.5% organic sales growth in 2017, which is in line with current market conditions. Adjusted EBITDA is forecasted to be $222 million and $224 million. Free Cash Flow before restructuring is forecasted to be between $80 million and $90 million. The company expects capital expenditures of $45 million and interest expense of $46 million.